{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-023358","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2022-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.414757+00:00","generated_at":"2026-06-27T13:35:16.137757+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Athira appoints Grant Pickering director; CEO gets $543k salary, 50% bonus target, enhanced severance","bullets":["Grant Pickering (CEO of Vaxcyte) appointed to board effective Jan 27, 2022.","CEO Mark Litton salary raised from $510k to $543,400; bonus target increased from 40% to 50%.","Amended severance: 12 months base salary (non-CIC) or 18 months salary + 150% bonus (CIC), plus equity acceleration.","Director compensation policy amended: $35k/year cash retainer; initial option grant 27,742 shares vesting monthly over 3 years; annual option grant 13,871 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-023358","json":"https://secwatch.observer/filing/0001193125-22-023358.json","markdown":"https://secwatch.observer/filing/0001193125-22-023358.md","text":"https://secwatch.observer/filing/0001193125-22-023358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000119312522023358/0001193125-22-023358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000119312522023358/d290928d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T13:35:16.137757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4cd2c6c022","claim":"Grant Pickering was appointed as Director at LeonaBio, Inc..","evidence_excerpt":"On January 27, 2022, the board of directors of Athira Pharma, Inc. (the “Company” or “Athira”), upon recommendation from the nominating and corporate governance committee of the Company’s board of directors (the “Board”), appointed Grant Pickering as a director of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312522023358/0001193125-22-023358-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}